Catalog |
name |
Description |
price |
R-M1-8565 |
(NH2-PEG2000-COOH)-KLVFF |
The PEGylation of the KLVFF peptide( (NH2-PEG2000-COOH)-KLVFF ) can provide several advantages, such as improved solubility, enhanced stability, and prolonged circulation time in vivo. This modified peptide conjugate may have potential applications in drug delivery systems and therapeutic interventions targeting Aβaggregation or related neurological disorders. |
price> |
R-M1-8578 |
Cholesterol-PEG2K-CGSPGWVRC |
Cholesterol-PEG2K-CGSPGWVRC represents a modified peptide or protein sequence. |
price> |
R-M1-8580 |
Cholesterol-PEG2000-CACSKPTDGNCT |
Cholesterol-PEG2000-CACSKPTDGNCT is a peptide sequence. |
price> |
R-M1-8633 |
NH2-PEG-LyP1 |
NH2-PEG-LyP1/Amine-peg-LyP1/amino-peg-LyP1/LyP1-peg-amino/LyP1-peg-NH2/LyP1-peg-amine is a heterobifunctional peg peptide reagent. LyP-1 is a 9-amino acid cyclic peptide identified by vivo phase display technology on the MDA-MB-435 human cardioma xenograft tutors. |
price> |
R-M1-8652 |
NH2-PEG5000-CREKA |
NH2-PEG5000-CREKA/NH2-PEG5000-CREKA(CYS-ARG-GLU-LYS-AlA)/Amine-PEG5000-CREKA(CYS-ARG-GLU-LYS-AlA)/CREKA-PEG5k-NH2/CREKA-PEG5k-Amine is a versatile composite material that combines the biocompatibility of PEG, the targeting ability of the CREKA peptide, and the flexibility of the amino group. Its potential applications in targeted drug delivery and molecular imaging make it an attractive candidate for biomedical research and applications in cancer therapy. |
price> |
R-M1-8653 |
Cholesterol-PEG2000-cys-YTIWMPENPRPGTPCDIFTNSRGKRASNG-K-FAM |
Cholesterol-PEG2000-cys-YTIWMPENPRPGTPCDIFTNSRGKRASNG-K-FAM/Cholesterol-PEG2000-cysteine-YTIWMPENPRPGTPCDIFTNSRGKRASNG-K-FAM/Cholesterol-PEG2000-cysteine-YTIWMPENPRPGTPCDIFTNSRGKRASNG-K-Carboxy fluorescein is a complex molecule that combines a cholesterol molecule, a PEG2000 polymer, a cysteine linker and a peptide sequence.Each component contributes to the molecule properties and potential applications. |
price> |
R-M1-8659 |
TAT-PEG2K-Chitosan |
Tat peptide (KYGRRRQRRKKRGC)-PEG2K-Chitosan/Tat(KYGRRRQRRKKRGC)-PEG2K-Chitosan/KYGRRRQRRKKRGC-PEG2K-Chitosan/Chitosan-PEG2K-KYGRRRQRRKKRGC/Chitosan-PEG2K-Tat(KYGRRRQRRKKRGC)/Chitosan-PEG2K-Tat(KYGRRRQRRKKRGC)/TAT-PEG2K-Chitosan is often utilized as a drug delivery system or as a carrier for delivering therapeutic agents into cells or tissues. The TAT peptide enables cellular uptake, while PEG2K and chitosan provide stability and biocompatibility to the system. The specific application and intended use of TAT-PEG2K-Chitosan may vary depending on the research or medical context. |
price> |
R-M1-8690 |
DMG-PEG2000-CARRPKFYRAPYVKNHPNVWGPWVAYGP |
DMG-PEG2000-CARRPKFYRAPYVKNHPNVWGPWVAYGP is a peptide modified peg compound.
Peptide sequence: CARRPKFYRAPYVKNHPNVWGPWVAYGP is an ST40 CD4 antibody mimetic. |
price> |
R-M1-8732 |
DMG-PEG2000-Gly Arg Thr Ile Ser Ser Val Ala Ile Thr Trp Ser Gly Asp Tyr Thr Ala Ala Asp Leu Arg Gly |
DMG-PEG2000-Gly Arg Thr Ile Ser Ser Val Ala Ile Thr Trp Ser Gly Asp Tyr Thr Ala Ala Asp Leu Arg Gly Gly Ser IleTyr Gly Thr Glu Asp Tyr Val is a heterobifunctional peptide sequence. |
price> |
R-M1-8744 |
Chol-peg2k-PLGVRG |
Cholesterol-peg2k-PLGVRG/Cholesterol-polyethylene glycol2k-PLGVRG/PLGVRG-polyethylene glycol2k-Cholesterol/PLGVRG-peg2k-PLGVRG/Chol-PEG2K-PLGVRG compound can potentially have improved stability, biocompatibility, solubility, and cellular uptake properties. This structure provides a balance between lipophilicity and water solubility, making it suitable for various biomedical applications, including targeted drug delivery, imaging, or tissue engineering. |
price> |